STAAR Surgical (NASDAQ:STAA) Given Average Rating of “Hold” by Analysts

STAAR Surgical (NASDAQ:STAA) has received an average rating of “Hold” from the nine analysts that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and four have given a buy rating to the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is $42.83.

A number of analysts have commented on STAA shares. Stephens raised STAAR Surgical to a “hold” rating in a report on Monday, December 2nd. Canaccord Genuity Group decreased their price target on STAAR Surgical from $31.00 to $28.00 and set a “hold” rating for the company in a report on Monday, December 9th. Finally, Needham & Company LLC restated a “hold” rating on shares of STAAR Surgical in a research note on Tuesday, January 7th.

Insider Buying and Selling

In other news, major shareholder Broadwood Partners, L.P. bought 53,500 shares of the stock in a transaction on Monday, December 16th. The shares were purchased at an average cost of $24.24 per share, for a total transaction of $1,296,840.00. Following the completion of the purchase, the insider now directly owns 10,821,931 shares in the company, valued at $262,323,607.44. This represents a 0.50 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In the last ninety days, insiders have purchased 105,876 shares of company stock valued at $2,487,168. 1.00% of the stock is owned by insiders.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the business. Dimensional Fund Advisors LP grew its holdings in STAAR Surgical by 25.9% during the 2nd quarter. Dimensional Fund Advisors LP now owns 459,655 shares of the medical instruments supplier’s stock valued at $21,884,000 after buying an additional 94,422 shares in the last quarter. Sei Investments Co. increased its holdings in STAAR Surgical by 2.7% during the 2nd quarter. Sei Investments Co. now owns 15,087 shares of the medical instruments supplier’s stock worth $718,000 after acquiring an additional 394 shares during the period. Squarepoint Ops LLC lifted its stake in STAAR Surgical by 108.1% in the 2nd quarter. Squarepoint Ops LLC now owns 62,772 shares of the medical instruments supplier’s stock worth $2,989,000 after purchasing an additional 32,602 shares in the last quarter. Millennium Management LLC grew its position in shares of STAAR Surgical by 84.2% during the 2nd quarter. Millennium Management LLC now owns 178,772 shares of the medical instruments supplier’s stock valued at $8,511,000 after purchasing an additional 81,738 shares in the last quarter. Finally, The Manufacturers Life Insurance Company increased its holdings in shares of STAAR Surgical by 16.2% in the second quarter. The Manufacturers Life Insurance Company now owns 27,008 shares of the medical instruments supplier’s stock worth $1,286,000 after purchasing an additional 3,758 shares during the period. 96.70% of the stock is currently owned by hedge funds and other institutional investors.

STAAR Surgical Price Performance

Shares of NASDAQ STAA opened at $23.22 on Friday. The company has a 50-day moving average price of $24.48 and a 200-day moving average price of $30.00. The stock has a market capitalization of $1.14 billion, a P/E ratio of 52.77 and a beta of 0.62. STAAR Surgical has a 1 year low of $21.13 and a 1 year high of $52.68.

About STAAR Surgical

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.